| Drug Type Non-recombinant coagulation factor | 
| Synonyms- | 
| Target | 
| Action modulators | 
| Mechanism fibrin modulators(Fibrin modulators), Fibrinogen  replacements(Fibrinogen  replacements) | 
| Therapeutic Areas | 
| Inactive Indication- | 
| Originator Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date China (01 Jan 1997),  | 
| Regulation- | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | - | - | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Afibrinogenemia | China  | 01 Jan 1997 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Acquired fibrinogen deficiency | IND Approval | China  | 28 Sep 2025 | |
| Congenital fibrinogen deficiency | IND Approval | China  | 28 Sep 2025 | 






